Question 1

What is BGLC stock price today?

Accepted Answer

BioNexus Gene Lab Corp. (BGLC) is currently trading at $2.03, up 1.49% today.

Question 2

What is BGLC market cap?

Accepted Answer

BioNexus Gene Lab Corp. has a market capitalization of $4 million, making it one of the notable companies in the Healthcare sector.

Question 3

What is BGLC P/E ratio?

Accepted Answer

BioNexus Gene Lab Corp. has a P/E ratio of -1.37, which measures the stock price relative to its earnings per share.

Question 4

What is BGLC 52-week high and low?

Accepted Answer

BioNexus Gene Lab Corp.'s 52-week high is $8.98 and 52-week low is $1.07. The current price of $2.03 is 12% of its 52-week range.

Question 5

What do analysts say about BGLC?

Accepted Answer

Analysts currently rate BioNexus Gene Lab Corp. as No Rating. Coverage is updated daily from major firms.

Question 6

Does BGLC pay a dividend?

Accepted Answer

BioNexus Gene Lab Corp. (BGLC) does not currently pay a dividend. The company reinvests profits back into growth and operations.

Question 7

Is BGLC revenue growing?

Accepted Answer

BioNexus Gene Lab Corp. has a year-over-year revenue growth rate of -80.8%. Revenue has declined compared to the prior year.

Question 8

What sector is BGLC in?

Accepted Answer

BioNexus Gene Lab Corp. (BGLC) operates in the Healthcare sector within the Medical - Diagnostics & Research industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 9

How has BGLC performed this year?

Accepted Answer

BioNexus Gene Lab Corp. (BGLC) has a year-to-date return of -49.4%. The stock has declined from its start-of-year price.

BioNexus Gene Lab Corp.

Price chart

Price performance

The thesis at a glance

Who's buying BGLC right now

Recent earnings results

Analyst coverage

How BGLC stacks vs Medical - Diagnostics & Research

Peers & themes